Cargando…

Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity

Despite the success of BCR‐ABL‐specific tyrosine kinase inhibitors (TKIs) such as imatinib in chronic phase (CP) chronic myeloid leukaemia (CML), patients with blast phase (BP)‐CML continue to have a dismal outcome with median survival of less than one year from diagnosis. Thus BP‐CML remains a crit...

Descripción completa

Detalles Bibliográficos
Autor principal:	Copland, Mhairi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796596/ https://www.ncbi.nlm.nih.gov/pubmed/35866251 http://dx.doi.org/10.1111/bjh.18370

Ejemplares similares

Consensus on BCR‐ABL1 reporting in chronic myeloid leukaemia in the UK
por: Cross, Nicholas C. P., et al.
Publicado: (2018)

BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia
por: Parry, Narissa, et al.
Publicado: (2022)

South African study of blast phase chronic myeloid leukaemia: A poor prognostic outlook
por: Hodkinson, Katherine E., et al.
Publicado: (2022)

Current Management of Chronic Myeloid Leukemia Myeloid Blast Phase
por: Yohanan, Binoy, et al.
Publicado: (2022)

A rare case of B-lymphoid blast phase of chronic myeloid leukemia: Diagnostic challenges
por: Naiyer, Nada, et al.
Publicado: (2022)

Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia.
por: Zalcberg, J. R., et al.
Publicado: (1986)

Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.
por: Gangal, S. G., et al.
Publicado: (1979)

The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022)

Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal
por: Toofan, Parto, et al.
Publicado: (2018)

Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia
por: Irvine, David A., et al.
Publicado: (2016)

Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape
por: Hsieh, Ya-Ching, et al.
Publicado: (2021)

Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases
por: Gu, Ruixin, et al.
Publicado: (2022)

B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
por: Yohannan, Binoy, et al.
Publicado: (2022)

A case of chronic myeloid leukaemia presenting as megakaryocytic blast crisis (AML M7)
por: Karkuzhali, Ponnuswamy, et al.
Publicado: (2013)

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia
por: Molica, Matteo, et al.
Publicado: (2019)

Spinal Chloroma – Herald of blast crisis in a patient with chronic myeloid leukaemia: A case report
por: Chandola, Stuti, et al.
Publicado: (2022)

Targeting self-renewal pathways in myeloid malignancies
por: Sands, William A, et al.
Publicado: (2013)

The application of BH3 mimetics in myeloid leukemias
por: Parry, Narissa, et al.
Publicado: (2021)

Atypical chronic myeloid leukaemia – a rare subtype of myelodysplastic/myeloproliferative neoplasm
por: Drozd-Sokołowska, Joanna E., et al.
Publicado: (2018)

NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
por: Forghieri, Fabio, et al.
Publicado: (2020)

Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
por: Poudel, Govinda, et al.
Publicado: (2022)

Prospects for achieving treatment‐free remission in chronic myeloid leukaemia
por: Saglio, Giuseppe, et al.
Publicado: (2020)

CBFA2T3‐GLIS2‐positive acute myeloid leukaemia. A peculiar paediatric entity
por: Masetti, Riccardo, et al.
Publicado: (2018)

Chronic Myeloid Leukaemia in The 21st Century
por: Frazer, Rachel, et al.
Publicado: (2007)

Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts.
por: Price, G., et al.
Publicado: (1987)

Cup‐like blasts in acute myeloid leukaemia with NPM1 and IDH2 mutations
por: Ohya, Eiko, et al.
Publicado: (2021)

Asciminib for chronic myeloid leukaemia
Publicado: (2022)

Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia
por: Vráblová, Lucia, et al.
Publicado: (2023)

The underestimated role of basophils in Ph(+) chronic myeloid leukaemia
por: Valent, Peter, et al.
Publicado: (2018)

Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
por: Carrà, Giovanna, et al.
Publicado: (2019)

Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
por: Kassem, Nancy, et al.
Publicado: (2023)

Pediatric chronic myeloid leukemia in myeloid blast crisis
por: Dey, Biswajit, et al.
Publicado: (2023)

Metabolic plasticity in blast crisis-chronic myeloid leukaemia cells under hypoxia reduces the cytotoxic potency of drugs targeting mitochondria
por: Salaverry, Luciana S., et al.
Publicado: (2022)

Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia
por: Chen, Z, et al.
Publicado: (2017)

Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
por: Angelopoulou, M K, et al.
Publicado: (2016)

Impact of frontline treatment approach on outcomes of myeloid blast phase CML
por: Saxena, Kapil, et al.
Publicado: (2021)

Chronic myeloid leukaemia with marked thrombocytosis
por: Ooi, Jun, et al.
Publicado: (2020)

Paediatric chronic myeloid leukaemia: Is it really a different disease?
por: Pushpam, Deepam, et al.
Publicado: (2019)

Desacetylmethylcolchicine in the Treatment of Myeloid Leukaemia
por: Jelliffe, A. M., et al.
Publicado: (1956)

Treatment Patterns in Patients with Chronic-Phase Chronic Myeloid Leukaemia in Routine Clinical Practice: the SIMPLICITY Italian Population
por: Abruzzese, Elisabetta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1mgqshajmb8vuae2pt2jl4rstg